Results 1 to 10 of about 2,436,024 (405)

Acknowledgment to the Reviewers of Current Oncology in 2022

Current Oncology, 2023
High-quality academic publishing is built on rigorous peer review [...]
Current Oncology Editorial Office
doaj   +1 more source

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2022
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type.
J. Ajani, T. D’amico, D. Bentrem, J. Chao, David Cooke, Carlos Corvera, P. Das, P. Enzinger, T. Enzler, P. Fanta, F. Farjah, H. Gerdes, M. Gibson, S. Hochwald, W. Hofstetter, D. Ilson, R. Keswani, Sunnie S Kim, L. Kleinberg, S. Klempner, J. Lacy, Quan P. Ly, K. Matkowskyj, M. Mcnamara, M. Mulcahy, D. Outlaw, Haeseong Park, K. Perry, J. Pimiento, G. Poultsides, S. Reznik, R. Roses, V. Strong, Stacey Su, Hanlin L. Wang, G. Wiesner, C. Willett, D. Yakoub, H. Yoon, Nicole R Mcmillian, L. Pluchino   +40 more
semanticscholar   +1 more source

Acknowledgment to Reviewers of Current Oncology in 2021

Current Oncology, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Current Oncology Editorial Office
doaj   +1 more source

Integrative Oncology [PDF]

Evidence-Based Complementary and Alternative Medicine, 2013
OA ...
Gustav Dobos, Holger Cramer, Shrikant Anant, Claudia M. Witt, Lorenzo Cohen   +4 more
openaire   +3 more sources

Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

The Journal of the National Comprehensive Cancer Network, 2021
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to ...
A. Benson, A. Venook, M. Al-Hawary, M. Arain, Yi-Jen Chen, K. Ciombor, S. Cohen, H. Cooper, D. Deming, L. Farkas, I. Garrido-Laguna, J. Grem, A. Gunn, J. Hecht, S. Hoffe, J. Hubbard, S. Hunt, K. Johung, Natalie N. Kirilcuk, S. Krishnamurthi, W. Messersmith, J. Meyerhardt, E. Miller, M. Mulcahy, Steven J. Nurkin, M. Overman, A. Parikh, Hitendra R. H. Patel, K. Pedersen, L. Saltz, C. Schneider, D. Shibata, J. Skibber, C. Sofocleous, E. Stoffel, E. Stotsky-Himelfarb, C. Willett, K. Gregory, Lisa A. Gurski   +38 more
semanticscholar   +1 more source

Citation analysis of Canadian psycho-oncology and supportive care researchers [PDF]

, 2013
Purpose: The purpose of this study was to conduct a historical review of psycho-oncology and supportive care research in Canada using citation analysis and to review the clinical impact of the research conducted by the most highly cited researchers ...
Crooks, Dauna, Hack, Thomas, Kepron, Emma, Plohman, James   +3 more
core   +1 more source

Oncology

Current Pharmaceutical Design, 2021

openaire   +2 more sources

Leveraging Large Language Models for Decision Support in Personalized Oncology

JAMA Network Open, 2023
Key Points Question Can current conversational large language models (LLMs) be used as a tool for personalized decision-making in precision oncology? Findings In this diagnostic study, treatment option identification from 4 LLMs for 10 fictional patients
M. Benary, Xing David Wang, Max Schmidt, D. Soll, G. Hilfenhaus, M. Nassir, C. Sigler, M. Knödler, U. Keller, D. Beule, U. Keilholz, Ulf Leser, D. Rieke   +12 more
semanticscholar   +1 more source

Clinical Practice Guidelines for Immune Checkpoint Inhibitor Therapy in Gynecological Tumors

Xiehe Yixue Zazhi, 2021
Immune checkpoint inhibitors (ICI) have shown efficacy for some patients with gynecological tumors, which are mainly used to treat persistent, recurrent, or metastatic patients.
Gynecological Oncology Society of Chinese Medical Association
doaj   +1 more source

Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy. [PDF]

, 2017
Current cell-free DNA (cfDNA) next generation sequencing (NGS) precision oncology workflows are typically limited to targeted and/or disease-specific applications.
Alva, Ajjai S, Brockman, Scott, Chinnaiyan, Arul M, Chugh, Rashmi, Feng, Felix Y, Grasso, Catherine S, Gursky, Amy, Haakenson, Christine, Henderson, James, Herman, Kirk, Hovelson, Daniel H, Husain, Hatim, Hussain, Maha H, Kamberov, Emmanuel, Kandarpa, Malathi, Kang, Qing, Krauss, John C, Langmore, John, Liu, Chia-Jen, Lonigro, Robert J, Mills, Ryan E, Morgan, Todd M, Quist, Michael J, Ramnath, Nithya, Robinson, Dan, Smith, David C, Talpaz, Moshe, Tesmer, Tim, Tewari, Muneesh, Tomlins, Scott A, Tuck, Missy, Wang, Yugang   +31 more
core   +1 more source